2017 American Transplant Congress
Center Volume Does Not Influence the Risk Associated with Using High DRI Donor Livers.
Background: High risk donor allografts potentially reduce survival after liver transplantation (LT), but increase access. We evaluated whether differences in patient mortality associated with using…2017 American Transplant Congress
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85: A Single Center Experience.
University of Virginia, Charlottesville, VA
In December 2014, UNOS implemented broad changes in the new Kidney Allocation System (KAS). Recent UNOS summary reports suggest that nationally, organ discard rates have…2017 American Transplant Congress
Controlled Donation After Circulatory Death (cDCD) Donors May Become Similar to Brain Death Donors (DBD).
Since 2014 in France, we started a cDCD program characterized by the introduction of normothermia regional perfusion (nRP) and selection criteria as donor age ≤65…2017 American Transplant Congress
Graft and Patient Survival in Liver Transplantation for Primary Sclerosing Cholangitis with Organs from DCD versus DBD Donors: Analysis of the UNOS Database.
Background: Primary sclerosing cholangitis (PSC) remains a major indication for liver transplantation (LT) worldwide. In an era of limited organ donation pool, assessment of PSC…2017 American Transplant Congress
A Novel KPD Mechanism to Increase Transplants When Some Candidates Have Multiple Willing Donors.
1Carnegie Mellon U, Pittsburgh; 2U of Maryland, College Park; 3UNOS, Richmond; 4Yale U, New Haven
Purpose: Current kidney exchanges such as the OPTN Kidney Paired Donation (KPD) program allow candidates to list multiple willing donors, but only one will donate…2017 American Transplant Congress
Post-Transplant Reduction in Pre-Existing Donor-Specific Antibody Levels After Belatacept- vs Cyclosporine-Based Immunosuppression.
1Emory University, Atlanta, GA; 2Bristol-Myers Squibb, Lawrenceville, NJ
Purpose: We explored the effect of belatacept (bela)- and cyclosporine (CsA)-based immunosuppression (IS) on pre-existing donor-specific antibody (DSA) levels by mean fluorescence intensity (MFI) in…2017 American Transplant Congress
Delayed Graft Function[mdash]Less Ominous for ARF or DCD Recipients?
University of Michigan, Ann Arbor
Delayed Graft Function (DGF) is both a transplant outcome and risk factor for graft failure. Kidneys from donors with kidney injury--such as acute renal failure…2017 American Transplant Congress
The Use of Kidneys from Deceased Donors Over 80 Years in Kidney Transplantation.
Patient survival is longer after kidney transplantation (KT) compared with remaining in the waiting list on dialysis. We have questioned if this is true also…2017 American Transplant Congress
Donor Families' Perspectives of the Harms of Failed Donation After Circulatory Death: A Qualitative Analysis.
Introduction: We sought to identify harms perceived by families of patients who underwent an unsuccessful attempt to donate organs after circulatory death.Methods: We identified a…2017 American Transplant Congress
Greater Emphasis on Non-Eligible Donors as a Strategy to Decrease the Organ Shortage.
Transplant, Mayo Clinic Florida, Jacksonville, FL
Background: OPO performance is generally evaluated by the number of organ procurement procedures divided by the number of eligible deaths(brain dead donors under age 70),…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 46
- Next Page »